Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mina Tadrous

Showing results (1-10 of 358) with videos related to

Pageof 36
Sort By:
Expert Review of Clinical Pharmacology|August 25, 2018
Opioids in Ontario: the current state of affairs and a path forwardMina Tadrous
Frontiers in Pharmacology|October 31, 2022
Editorial: Shaping with data: Using pharmacoepidemiology to shape pharmaceutical policy and clinical decision-makingMina Tadrous, Andrea Burden
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 21, 2021
Old dog with new tricks: An introduction to real-world evidence for pharmacistsDonna Rahmatian, Mina Tadrous
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|November 4, 2014
Proceed with caution: The possible impact of preferred-provider networksJohn Greiss, Mina Tadrous
Infection Control and Hospital Epidemiology|March 29, 2021
Sum of the parts: Ensuring a resilient global drug supply chainKatie J Suda, Mina Tadrous
JAMA Dermatology|August 14, 2020
Topical Calcineurin Inhibitors and Skin Cancer-Another Piece of the PuzzleAaron M Drucker, Mina Tadrous
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|October 7, 2025
Empowering pharmacists in Canada's drug shortage responsePeter Chengming Zhang, Mina Tadrous
British Journal of Clinical Pharmacology|October 19, 2020
The missed opportunity for real-world evidence to shape our understanding of medical cannabisAhmad Shakeri, Maria Zhang, Mina Tadrous
Journal of Affective Disorders|February 17, 2012
Does depression lead to influenza? - A systematic literature analysisDaniel Gharbawy, Mina Tadrous, Katie Suda
Clinical Pharmacology and Therapeutics|September 10, 2020
Potential Cost Implications of Mandatory Non-Medical Switching Policies for Biologics for Rheumatic Conditions and Inflammatory Bowel Disease in CanadaMichael Crosby, Mina Tadrous, Tara Gomes
Pageof 36

Showing results (1-10 of 358) with videos related to

Sort By:
Pageof 36
Expert Review of Clinical Pharmacology|August 25, 2018
Opioids in Ontario: the current state of affairs and a path forwardMina Tadrous
Frontiers in Pharmacology|October 31, 2022
Editorial: Shaping with data: Using pharmacoepidemiology to shape pharmaceutical policy and clinical decision-makingMina Tadrous, Andrea Burden
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 21, 2021
Old dog with new tricks: An introduction to real-world evidence for pharmacistsDonna Rahmatian, Mina Tadrous
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|November 4, 2014
Proceed with caution: The possible impact of preferred-provider networksJohn Greiss, Mina Tadrous
Infection Control and Hospital Epidemiology|March 29, 2021
Sum of the parts: Ensuring a resilient global drug supply chainKatie J Suda, Mina Tadrous
JAMA Dermatology|August 14, 2020
Topical Calcineurin Inhibitors and Skin Cancer-Another Piece of the PuzzleAaron M Drucker, Mina Tadrous
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|October 7, 2025
Empowering pharmacists in Canada's drug shortage responsePeter Chengming Zhang, Mina Tadrous
British Journal of Clinical Pharmacology|October 19, 2020
The missed opportunity for real-world evidence to shape our understanding of medical cannabisAhmad Shakeri, Maria Zhang, Mina Tadrous
Journal of Affective Disorders|February 17, 2012
Does depression lead to influenza? - A systematic literature analysisDaniel Gharbawy, Mina Tadrous, Katie Suda
Clinical Pharmacology and Therapeutics|September 10, 2020
Potential Cost Implications of Mandatory Non-Medical Switching Policies for Biologics for Rheumatic Conditions and Inflammatory Bowel Disease in CanadaMichael Crosby, Mina Tadrous, Tara Gomes
Pageof 36